lapatinib has been researched along with 1-deoxynojirimycin hydrochloride in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (1-deoxynojirimycin hydrochloride) | Trials (1-deoxynojirimycin hydrochloride) | Recent Studies (post-2010) (1-deoxynojirimycin hydrochloride) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 6 | 0 | 3 |
| Protein | Taxonomy | lapatinib (IC50) | 1-deoxynojirimycin hydrochloride (IC50) |
|---|---|---|---|
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 10 | |
| Killer cell lectin-like receptor subfamily B member 1A | Rattus norvegicus (Norway rat) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Gao, H; Li, B; Li, X; Liu, J; Liu, R; Wang, W; Zhang, Y; Zhao, L | 1 |
1 other study(ies) available for lapatinib and 1-deoxynojirimycin hydrochloride
| Article | Year |
|---|---|
Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and α-glucosidase.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Dose-Response Relationship, Drug; ErbB Receptors; Glycoside Hydrolase Inhibitors; Humans; Molecular Structure; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship | 2017 |